nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolcapone—Niclosamide—STAT3—liver cancer	0.0338	1	CrCbGaD
Tolcapone—COMT—Estrogen metabolism—GSTA1—liver cancer	0.0174	0.076	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—UGDH—liver cancer	0.00991	0.0433	CbGpPWpGaD
Tolcapone—COMT—Estrogen metabolism—GSTM1—liver cancer	0.0085	0.0371	CbGpPWpGaD
Tolcapone—COMT—Estrogen metabolism—CYP1A1—liver cancer	0.00806	0.0352	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—UGDH—liver cancer	0.0058	0.0253	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTA3—liver cancer	0.00569	0.0248	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTA4—liver cancer	0.0052	0.0227	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTA2—liver cancer	0.00507	0.0221	CbGpPWpGaD
Tolcapone—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—liver cancer	0.00506	0.0221	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTA1—liver cancer	0.00489	0.0214	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—NAT2—liver cancer	0.00484	0.0211	CbGpPWpGaD
Tolcapone—CYP2C9—CYP2E1 reactions—CYP2E1—liver cancer	0.00427	0.0187	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—liver cancer	0.00396	0.0173	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—HPGDS—liver cancer	0.00387	0.0169	CbGpPWpGaD
Tolcapone—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—liver cancer	0.0036	0.0157	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—NR1H4—liver cancer	0.00339	0.0148	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTA3—liver cancer	0.00333	0.0145	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTA3—liver cancer	0.00328	0.0143	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00328	0.0143	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00318	0.0139	CbGpPWpGaD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00313	0.0136	CbGpPWpGaD
Tolcapone—COMT—Transmission across Chemical Synapses—GLUL—liver cancer	0.00311	0.0136	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTA4—liver cancer	0.00304	0.0133	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GSTA4—liver cancer	0.003	0.0131	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTA2—liver cancer	0.00297	0.013	CbGpPWpGaD
Tolcapone—CYP2C9—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00292	0.0128	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GGT1—liver cancer	0.00289	0.0126	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—GSTA1—liver cancer	0.00286	0.0125	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—NAT2—liver cancer	0.00283	0.0124	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—NAT2—liver cancer	0.00279	0.0122	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP2E1—liver cancer	0.00265	0.0116	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTP1—liver cancer	0.0026	0.0114	CbGpPWpGaD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP2E1—liver cancer	0.00255	0.0111	CbGpPWpGaD
Tolcapone—COMT—Phase II conjugation—GSTM1—liver cancer	0.00239	0.0104	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—GLUL—liver cancer	0.00238	0.0104	CbGpPWpGaD
Tolcapone—COMT—Metapathway biotransformation—GPX3—liver cancer	0.00237	0.0104	CbGpPWpGaD
Tolcapone—COMT—Biological oxidations—HPGDS—liver cancer	0.00226	0.00988	CbGpPWpGaD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00202	0.00881	CbGpPWpGaD
Tolcapone—CYP2C9—Xenobiotics—CYP1A1—liver cancer	0.0019	0.00831	CbGpPWpGaD
Tolcapone—Mental disability—Epirubicin—liver cancer	0.00188	0.00256	CcSEcCtD
Tolcapone—Dyspnoea—Sorafenib—liver cancer	0.00187	0.00254	CcSEcCtD
Tolcapone—Dyspepsia—Sorafenib—liver cancer	0.00185	0.0025	CcSEcCtD
Tolcapone—COMT—Biological oxidations—CYP2E1—liver cancer	0.00184	0.00805	CbGpPWpGaD
Tolcapone—Oesophagitis—Doxorubicin—liver cancer	0.00184	0.00249	CcSEcCtD
Tolcapone—CYP2C9—Tamoxifen metabolism—CYP1A1—liver cancer	0.00183	0.00799	CbGpPWpGaD
Tolcapone—Decreased appetite—Sorafenib—liver cancer	0.00182	0.00247	CcSEcCtD
Tolcapone—COMT—Metapathway biotransformation—CYP2E1—liver cancer	0.00182	0.00794	CbGpPWpGaD
Tolcapone—Neoplasm—Doxorubicin—liver cancer	0.00182	0.00247	CcSEcCtD
Tolcapone—Mouth ulceration—Doxorubicin—liver cancer	0.00182	0.00247	CcSEcCtD
Tolcapone—Diabetes mellitus—Epirubicin—liver cancer	0.00181	0.00246	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Sorafenib—liver cancer	0.00181	0.00246	CcSEcCtD
Tolcapone—Fatigue—Sorafenib—liver cancer	0.00181	0.00245	CcSEcCtD
Tolcapone—Pain—Sorafenib—liver cancer	0.00179	0.00243	CcSEcCtD
Tolcapone—Constipation—Sorafenib—liver cancer	0.00179	0.00243	CcSEcCtD
Tolcapone—Pulmonary oedema—Doxorubicin—liver cancer	0.00179	0.00243	CcSEcCtD
Tolcapone—Hypertonia—Doxorubicin—liver cancer	0.00176	0.00239	CcSEcCtD
Tolcapone—Eczema—Epirubicin—liver cancer	0.00175	0.00238	CcSEcCtD
Tolcapone—Eye pain—Epirubicin—liver cancer	0.00175	0.00237	CcSEcCtD
Tolcapone—Mental disability—Doxorubicin—liver cancer	0.00174	0.00237	CcSEcCtD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.00173	0.00756	CbGpPWpGaD
Tolcapone—Gastrointestinal pain—Sorafenib—liver cancer	0.00171	0.00233	CcSEcCtD
Tolcapone—COMT—Biological oxidations—GGT1—liver cancer	0.00169	0.00739	CbGpPWpGaD
Tolcapone—Diabetes mellitus—Doxorubicin—liver cancer	0.00168	0.00228	CcSEcCtD
Tolcapone—Urticaria—Sorafenib—liver cancer	0.00167	0.00226	CcSEcCtD
Tolcapone—Abdominal pain—Sorafenib—liver cancer	0.00166	0.00225	CcSEcCtD
Tolcapone—Body temperature increased—Sorafenib—liver cancer	0.00166	0.00225	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.00164	0.00715	CbGpPWpGaD
Tolcapone—Eczema—Doxorubicin—liver cancer	0.00162	0.0022	CcSEcCtD
Tolcapone—Eye pain—Doxorubicin—liver cancer	0.00162	0.00219	CcSEcCtD
Tolcapone—Cardiac failure—Epirubicin—liver cancer	0.00162	0.00219	CcSEcCtD
Tolcapone—Lethargy—Epirubicin—liver cancer	0.00161	0.00218	CcSEcCtD
Tolcapone—Cerebrovascular accident—Epirubicin—liver cancer	0.00161	0.00218	CcSEcCtD
Tolcapone—Osteoarthritis—Epirubicin—liver cancer	0.00158	0.00214	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.00158	0.00214	CcSEcCtD
Tolcapone—Diplopia—Epirubicin—liver cancer	0.00158	0.00214	CcSEcCtD
Tolcapone—CYP2C9—Arachidonic acid metabolism—HPGDS—liver cancer	0.00156	0.00681	CbGpPWpGaD
Tolcapone—Affect lability—Epirubicin—liver cancer	0.00155	0.00211	CcSEcCtD
Tolcapone—Migraine—Epirubicin—liver cancer	0.00155	0.00211	CcSEcCtD
Tolcapone—Hypersensitivity—Sorafenib—liver cancer	0.00154	0.0021	CcSEcCtD
Tolcapone—Face oedema—Epirubicin—liver cancer	0.00152	0.00206	CcSEcCtD
Tolcapone—COMT—Biological oxidations—GSTP1—liver cancer	0.00152	0.00664	CbGpPWpGaD
Tolcapone—Asthenia—Sorafenib—liver cancer	0.0015	0.00204	CcSEcCtD
Tolcapone—COMT—Metapathway biotransformation—GSTP1—liver cancer	0.0015	0.00655	CbGpPWpGaD
Tolcapone—Cardiac arrest—Epirubicin—liver cancer	0.0015	0.00203	CcSEcCtD
Tolcapone—Cardiac failure—Doxorubicin—liver cancer	0.00149	0.00203	CcSEcCtD
Tolcapone—Mood swings—Epirubicin—liver cancer	0.00149	0.00203	CcSEcCtD
Tolcapone—Cerebrovascular accident—Doxorubicin—liver cancer	0.00149	0.00202	CcSEcCtD
Tolcapone—Lethargy—Doxorubicin—liver cancer	0.00149	0.00202	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—UGDH—liver cancer	0.00149	0.0065	CbGpPWpGaD
Tolcapone—Pruritus—Sorafenib—liver cancer	0.00148	0.00201	CcSEcCtD
Tolcapone—Dehydration—Epirubicin—liver cancer	0.00147	0.00199	CcSEcCtD
Tolcapone—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.00146	0.00198	CcSEcCtD
Tolcapone—Diplopia—Doxorubicin—liver cancer	0.00146	0.00198	CcSEcCtD
Tolcapone—Osteoarthritis—Doxorubicin—liver cancer	0.00146	0.00198	CcSEcCtD
Tolcapone—Migraine—Doxorubicin—liver cancer	0.00144	0.00195	CcSEcCtD
Tolcapone—Affect lability—Doxorubicin—liver cancer	0.00144	0.00195	CcSEcCtD
Tolcapone—Diarrhoea—Sorafenib—liver cancer	0.00143	0.00195	CcSEcCtD
Tolcapone—Face oedema—Doxorubicin—liver cancer	0.00141	0.00191	CcSEcCtD
Tolcapone—COMT—Biological oxidations—GSTM1—liver cancer	0.0014	0.0061	CbGpPWpGaD
Tolcapone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00139	0.00189	CcSEcCtD
Tolcapone—Cardiac arrest—Doxorubicin—liver cancer	0.00139	0.00188	CcSEcCtD
Tolcapone—Dizziness—Sorafenib—liver cancer	0.00139	0.00188	CcSEcCtD
Tolcapone—Mood swings—Doxorubicin—liver cancer	0.00138	0.00187	CcSEcCtD
Tolcapone—COMT—Metapathway biotransformation—GSTM1—liver cancer	0.00138	0.00602	CbGpPWpGaD
Tolcapone—Dysphagia—Epirubicin—liver cancer	0.00136	0.00185	CcSEcCtD
Tolcapone—Influenza—Epirubicin—liver cancer	0.00136	0.00185	CcSEcCtD
Tolcapone—Asthma—Epirubicin—liver cancer	0.00136	0.00185	CcSEcCtD
Tolcapone—Dehydration—Doxorubicin—liver cancer	0.00136	0.00184	CcSEcCtD
Tolcapone—Vomiting—Sorafenib—liver cancer	0.00133	0.00181	CcSEcCtD
Tolcapone—Angina pectoris—Epirubicin—liver cancer	0.00133	0.0018	CcSEcCtD
Tolcapone—COMT—Biological oxidations—CYP1A1—liver cancer	0.00133	0.00579	CbGpPWpGaD
Tolcapone—Rash—Sorafenib—liver cancer	0.00132	0.00179	CcSEcCtD
Tolcapone—Dermatitis—Sorafenib—liver cancer	0.00132	0.00179	CcSEcCtD
Tolcapone—Headache—Sorafenib—liver cancer	0.00131	0.00178	CcSEcCtD
Tolcapone—Bronchitis—Epirubicin—liver cancer	0.00131	0.00178	CcSEcCtD
Tolcapone—COMT—Metapathway biotransformation—CYP1A1—liver cancer	0.00131	0.00571	CbGpPWpGaD
Tolcapone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00129	0.00175	CcSEcCtD
Tolcapone—Dysuria—Epirubicin—liver cancer	0.00127	0.00173	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Epirubicin—liver cancer	0.00127	0.00172	CcSEcCtD
Tolcapone—Dysphagia—Doxorubicin—liver cancer	0.00126	0.00171	CcSEcCtD
Tolcapone—Asthma—Doxorubicin—liver cancer	0.00126	0.00171	CcSEcCtD
Tolcapone—Influenza—Doxorubicin—liver cancer	0.00126	0.00171	CcSEcCtD
Tolcapone—Pollakiuria—Epirubicin—liver cancer	0.00126	0.00171	CcSEcCtD
Tolcapone—Nausea—Sorafenib—liver cancer	0.00125	0.00169	CcSEcCtD
Tolcapone—Weight decreased—Epirubicin—liver cancer	0.00123	0.00167	CcSEcCtD
Tolcapone—Angina pectoris—Doxorubicin—liver cancer	0.00123	0.00167	CcSEcCtD
Tolcapone—Pneumonia—Epirubicin—liver cancer	0.00122	0.00166	CcSEcCtD
Tolcapone—Infestation NOS—Epirubicin—liver cancer	0.00122	0.00165	CcSEcCtD
Tolcapone—Infestation—Epirubicin—liver cancer	0.00122	0.00165	CcSEcCtD
Tolcapone—Bronchitis—Doxorubicin—liver cancer	0.00121	0.00165	CcSEcCtD
Tolcapone—Neuropathy peripheral—Epirubicin—liver cancer	0.00119	0.00162	CcSEcCtD
Tolcapone—Stomatitis—Epirubicin—liver cancer	0.00118	0.00161	CcSEcCtD
Tolcapone—Urinary tract infection—Epirubicin—liver cancer	0.00118	0.0016	CcSEcCtD
Tolcapone—Dysuria—Doxorubicin—liver cancer	0.00118	0.0016	CcSEcCtD
Tolcapone—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00117	0.00159	CcSEcCtD
Tolcapone—CYP2C9—Arachidonic acid metabolism—GGT1—liver cancer	0.00117	0.0051	CbGpPWpGaD
Tolcapone—Sweating—Epirubicin—liver cancer	0.00116	0.00158	CcSEcCtD
Tolcapone—Pollakiuria—Doxorubicin—liver cancer	0.00116	0.00158	CcSEcCtD
Tolcapone—Haematuria—Epirubicin—liver cancer	0.00116	0.00157	CcSEcCtD
Tolcapone—Epistaxis—Epirubicin—liver cancer	0.00115	0.00155	CcSEcCtD
Tolcapone—Weight decreased—Doxorubicin—liver cancer	0.00114	0.00155	CcSEcCtD
Tolcapone—Sinusitis—Epirubicin—liver cancer	0.00114	0.00155	CcSEcCtD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.00114	0.00497	CbGpPWpGaD
Tolcapone—Pneumonia—Doxorubicin—liver cancer	0.00113	0.00153	CcSEcCtD
Tolcapone—Infestation—Doxorubicin—liver cancer	0.00112	0.00153	CcSEcCtD
Tolcapone—Infestation NOS—Doxorubicin—liver cancer	0.00112	0.00153	CcSEcCtD
Tolcapone—Bradycardia—Epirubicin—liver cancer	0.00111	0.00151	CcSEcCtD
Tolcapone—Neuropathy peripheral—Doxorubicin—liver cancer	0.0011	0.0015	CcSEcCtD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.0011	0.0048	CbGpPWpGaD
Tolcapone—Haemoglobin—Epirubicin—liver cancer	0.0011	0.00149	CcSEcCtD
Tolcapone—Stomatitis—Doxorubicin—liver cancer	0.0011	0.00149	CcSEcCtD
Tolcapone—Rhinitis—Epirubicin—liver cancer	0.00109	0.00148	CcSEcCtD
Tolcapone—Urinary tract infection—Doxorubicin—liver cancer	0.00109	0.00148	CcSEcCtD
Tolcapone—Haemorrhage—Epirubicin—liver cancer	0.00109	0.00148	CcSEcCtD
Tolcapone—Hypoaesthesia—Epirubicin—liver cancer	0.00109	0.00147	CcSEcCtD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.00109	0.00474	CbGpPWpGaD
Tolcapone—Pharyngitis—Epirubicin—liver cancer	0.00108	0.00147	CcSEcCtD
Tolcapone—Sweating—Doxorubicin—liver cancer	0.00108	0.00146	CcSEcCtD
Tolcapone—Urinary tract disorder—Epirubicin—liver cancer	0.00108	0.00146	CcSEcCtD
Tolcapone—Oedema peripheral—Epirubicin—liver cancer	0.00107	0.00146	CcSEcCtD
Tolcapone—Haematuria—Doxorubicin—liver cancer	0.00107	0.00145	CcSEcCtD
Tolcapone—Urethral disorder—Epirubicin—liver cancer	0.00107	0.00145	CcSEcCtD
Tolcapone—Epistaxis—Doxorubicin—liver cancer	0.00106	0.00144	CcSEcCtD
Tolcapone—Sinusitis—Doxorubicin—liver cancer	0.00105	0.00143	CcSEcCtD
Tolcapone—Erythema multiforme—Epirubicin—liver cancer	0.00103	0.0014	CcSEcCtD
Tolcapone—Bradycardia—Doxorubicin—liver cancer	0.00103	0.00139	CcSEcCtD
Tolcapone—Tinnitus—Epirubicin—liver cancer	0.00102	0.00138	CcSEcCtD
Tolcapone—Haemoglobin—Doxorubicin—liver cancer	0.00101	0.00138	CcSEcCtD
Tolcapone—Rhinitis—Doxorubicin—liver cancer	0.00101	0.00137	CcSEcCtD
Tolcapone—Haemorrhage—Doxorubicin—liver cancer	0.00101	0.00137	CcSEcCtD
Tolcapone—Hypoaesthesia—Doxorubicin—liver cancer	0.001	0.00136	CcSEcCtD
Tolcapone—Pharyngitis—Doxorubicin—liver cancer	0.001	0.00136	CcSEcCtD
Tolcapone—Urinary tract disorder—Doxorubicin—liver cancer	0.000997	0.00135	CcSEcCtD
Tolcapone—Oedema peripheral—Doxorubicin—liver cancer	0.000994	0.00135	CcSEcCtD
Tolcapone—COMT—Metabolism—UGDH—liver cancer	0.000991	0.00433	CbGpPWpGaD
Tolcapone—Angiopathy—Epirubicin—liver cancer	0.00099	0.00134	CcSEcCtD
Tolcapone—Urethral disorder—Doxorubicin—liver cancer	0.000989	0.00134	CcSEcCtD
Tolcapone—Mediastinal disorder—Epirubicin—liver cancer	0.000983	0.00133	CcSEcCtD
Tolcapone—Chills—Epirubicin—liver cancer	0.000979	0.00133	CcSEcCtD
Tolcapone—Arrhythmia—Epirubicin—liver cancer	0.000974	0.00132	CcSEcCtD
Tolcapone—Alopecia—Epirubicin—liver cancer	0.000964	0.00131	CcSEcCtD
Tolcapone—Mental disorder—Epirubicin—liver cancer	0.000956	0.0013	CcSEcCtD
Tolcapone—Erythema multiforme—Doxorubicin—liver cancer	0.000954	0.00129	CcSEcCtD
Tolcapone—Tinnitus—Doxorubicin—liver cancer	0.000941	0.00128	CcSEcCtD
Tolcapone—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000941	0.00411	CbGpPWpGaD
Tolcapone—Flatulence—Epirubicin—liver cancer	0.000936	0.00127	CcSEcCtD
Tolcapone—COMT—Metabolism—EPT1—liver cancer	0.000932	0.00407	CbGpPWpGaD
Tolcapone—Tension—Epirubicin—liver cancer	0.000932	0.00126	CcSEcCtD
Tolcapone—Dysgeusia—Epirubicin—liver cancer	0.00093	0.00126	CcSEcCtD
Tolcapone—Nervousness—Epirubicin—liver cancer	0.000922	0.00125	CcSEcCtD
Tolcapone—Angiopathy—Doxorubicin—liver cancer	0.000916	0.00124	CcSEcCtD
Tolcapone—CYP2C9—Arachidonic acid metabolism—CYP1A1—liver cancer	0.000914	0.00399	CbGpPWpGaD
Tolcapone—Muscle spasms—Epirubicin—liver cancer	0.000913	0.00124	CcSEcCtD
Tolcapone—Mediastinal disorder—Doxorubicin—liver cancer	0.00091	0.00123	CcSEcCtD
Tolcapone—Chills—Doxorubicin—liver cancer	0.000906	0.00123	CcSEcCtD
Tolcapone—Arrhythmia—Doxorubicin—liver cancer	0.000902	0.00122	CcSEcCtD
Tolcapone—Vision blurred—Epirubicin—liver cancer	0.000895	0.00121	CcSEcCtD
Tolcapone—Alopecia—Doxorubicin—liver cancer	0.000892	0.00121	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000891	0.00389	CbGpPWpGaD
Tolcapone—Mental disorder—Doxorubicin—liver cancer	0.000884	0.0012	CcSEcCtD
Tolcapone—COMT—Metabolism—TAT—liver cancer	0.000883	0.00386	CbGpPWpGaD
Tolcapone—Ill-defined disorder—Epirubicin—liver cancer	0.000881	0.0012	CcSEcCtD
Tolcapone—Anaemia—Epirubicin—liver cancer	0.000878	0.00119	CcSEcCtD
Tolcapone—Agitation—Epirubicin—liver cancer	0.000873	0.00118	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—NR1H4—liver cancer	0.000869	0.0038	CbGpPWpGaD
Tolcapone—Flatulence—Doxorubicin—liver cancer	0.000866	0.00117	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—BRAF—liver cancer	0.000865	0.00378	CbGpPWpGaD
Tolcapone—Tension—Doxorubicin—liver cancer	0.000862	0.00117	CcSEcCtD
Tolcapone—Dysgeusia—Doxorubicin—liver cancer	0.00086	0.00117	CcSEcCtD
Tolcapone—Malaise—Epirubicin—liver cancer	0.000856	0.00116	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTA3—liver cancer	0.000855	0.00373	CbGpPWpGaD
Tolcapone—Nervousness—Doxorubicin—liver cancer	0.000853	0.00116	CcSEcCtD
Tolcapone—Vertigo—Epirubicin—liver cancer	0.000853	0.00116	CcSEcCtD
Tolcapone—Syncope—Epirubicin—liver cancer	0.000852	0.00116	CcSEcCtD
Tolcapone—Muscle spasms—Doxorubicin—liver cancer	0.000845	0.00115	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTA3—liver cancer	0.000843	0.00368	CbGpPWpGaD
Tolcapone—Palpitations—Epirubicin—liver cancer	0.000839	0.00114	CcSEcCtD
Tolcapone—Loss of consciousness—Epirubicin—liver cancer	0.000835	0.00113	CcSEcCtD
Tolcapone—Cough—Epirubicin—liver cancer	0.000829	0.00112	CcSEcCtD
Tolcapone—Vision blurred—Doxorubicin—liver cancer	0.000828	0.00112	CcSEcCtD
Tolcapone—Hypertension—Epirubicin—liver cancer	0.00082	0.00111	CcSEcCtD
Tolcapone—Ill-defined disorder—Doxorubicin—liver cancer	0.000815	0.00111	CcSEcCtD
Tolcapone—Anaemia—Doxorubicin—liver cancer	0.000812	0.0011	CcSEcCtD
Tolcapone—Myalgia—Epirubicin—liver cancer	0.000808	0.0011	CcSEcCtD
Tolcapone—Arthralgia—Epirubicin—liver cancer	0.000808	0.0011	CcSEcCtD
Tolcapone—Chest pain—Epirubicin—liver cancer	0.000808	0.0011	CcSEcCtD
Tolcapone—Agitation—Doxorubicin—liver cancer	0.000807	0.0011	CcSEcCtD
Tolcapone—Anxiety—Epirubicin—liver cancer	0.000806	0.00109	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000803	0.00109	CcSEcCtD
Tolcapone—Discomfort—Epirubicin—liver cancer	0.000799	0.00108	CcSEcCtD
Tolcapone—Malaise—Doxorubicin—liver cancer	0.000792	0.00107	CcSEcCtD
Tolcapone—Dry mouth—Epirubicin—liver cancer	0.000791	0.00107	CcSEcCtD
Tolcapone—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.00079	0.00345	CbGpPWpGaD
Tolcapone—Vertigo—Doxorubicin—liver cancer	0.000789	0.00107	CcSEcCtD
Tolcapone—Syncope—Doxorubicin—liver cancer	0.000788	0.00107	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTA4—liver cancer	0.000782	0.00341	CbGpPWpGaD
Tolcapone—Confusional state—Epirubicin—liver cancer	0.000781	0.00106	CcSEcCtD
Tolcapone—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.00078	0.0034	CbGpPWpGaD
Tolcapone—Palpitations—Doxorubicin—liver cancer	0.000776	0.00105	CcSEcCtD
Tolcapone—Oedema—Epirubicin—liver cancer	0.000775	0.00105	CcSEcCtD
Tolcapone—Loss of consciousness—Doxorubicin—liver cancer	0.000772	0.00105	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTA4—liver cancer	0.000771	0.00337	CbGpPWpGaD
Tolcapone—Infection—Epirubicin—liver cancer	0.00077	0.00104	CcSEcCtD
Tolcapone—Cough—Doxorubicin—liver cancer	0.000767	0.00104	CcSEcCtD
Tolcapone—Shock—Epirubicin—liver cancer	0.000762	0.00103	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTA2—liver cancer	0.000762	0.00333	CbGpPWpGaD
Tolcapone—Nervous system disorder—Epirubicin—liver cancer	0.00076	0.00103	CcSEcCtD
Tolcapone—Thrombocytopenia—Epirubicin—liver cancer	0.000759	0.00103	CcSEcCtD
Tolcapone—Hypertension—Doxorubicin—liver cancer	0.000759	0.00103	CcSEcCtD
Tolcapone—Tachycardia—Epirubicin—liver cancer	0.000756	0.00103	CcSEcCtD
Tolcapone—Skin disorder—Epirubicin—liver cancer	0.000753	0.00102	CcSEcCtD
Tolcapone—Hyperhidrosis—Epirubicin—liver cancer	0.000749	0.00102	CcSEcCtD
Tolcapone—Chest pain—Doxorubicin—liver cancer	0.000748	0.00101	CcSEcCtD
Tolcapone—Myalgia—Doxorubicin—liver cancer	0.000748	0.00101	CcSEcCtD
Tolcapone—Arthralgia—Doxorubicin—liver cancer	0.000748	0.00101	CcSEcCtD
Tolcapone—Anxiety—Doxorubicin—liver cancer	0.000745	0.00101	CcSEcCtD
Tolcapone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000743	0.00101	CcSEcCtD
Tolcapone—Discomfort—Doxorubicin—liver cancer	0.000739	0.001	CcSEcCtD
Tolcapone—Anorexia—Epirubicin—liver cancer	0.000739	0.001	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—GSTA1—liver cancer	0.000735	0.00321	CbGpPWpGaD
Tolcapone—Dry mouth—Doxorubicin—liver cancer	0.000732	0.000992	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—NAT2—liver cancer	0.000727	0.00317	CbGpPWpGaD
Tolcapone—Hypotension—Epirubicin—liver cancer	0.000724	0.000982	CcSEcCtD
Tolcapone—Confusional state—Doxorubicin—liver cancer	0.000723	0.000981	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—RAF1—liver cancer	0.000722	0.00315	CbGpPWpGaD
Tolcapone—Oedema—Doxorubicin—liver cancer	0.000717	0.000973	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—NAT2—liver cancer	0.000717	0.00313	CbGpPWpGaD
Tolcapone—Infection—Doxorubicin—liver cancer	0.000712	0.000966	CcSEcCtD
Tolcapone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000706	0.000958	CcSEcCtD
Tolcapone—Shock—Doxorubicin—liver cancer	0.000705	0.000957	CcSEcCtD
Tolcapone—Nervous system disorder—Doxorubicin—liver cancer	0.000703	0.000954	CcSEcCtD
Tolcapone—Thrombocytopenia—Doxorubicin—liver cancer	0.000702	0.000952	CcSEcCtD
Tolcapone—Tachycardia—Doxorubicin—liver cancer	0.0007	0.000949	CcSEcCtD
Tolcapone—Skin disorder—Doxorubicin—liver cancer	0.000696	0.000945	CcSEcCtD
Tolcapone—Paraesthesia—Epirubicin—liver cancer	0.000696	0.000944	CcSEcCtD
Tolcapone—Hyperhidrosis—Doxorubicin—liver cancer	0.000693	0.00094	CcSEcCtD
Tolcapone—Dyspnoea—Epirubicin—liver cancer	0.000691	0.000937	CcSEcCtD
Tolcapone—Somnolence—Epirubicin—liver cancer	0.000689	0.000935	CcSEcCtD
Tolcapone—Anorexia—Doxorubicin—liver cancer	0.000683	0.000927	CcSEcCtD
Tolcapone—Dyspepsia—Epirubicin—liver cancer	0.000682	0.000925	CcSEcCtD
Tolcapone—Decreased appetite—Epirubicin—liver cancer	0.000674	0.000914	CcSEcCtD
Tolcapone—Hypotension—Doxorubicin—liver cancer	0.00067	0.000909	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Epirubicin—liver cancer	0.000669	0.000908	CcSEcCtD
Tolcapone—Fatigue—Epirubicin—liver cancer	0.000668	0.000906	CcSEcCtD
Tolcapone—Pain—Epirubicin—liver cancer	0.000663	0.000899	CcSEcCtD
Tolcapone—Constipation—Epirubicin—liver cancer	0.000663	0.000899	CcSEcCtD
Tolcapone—COMT—Neuronal System—BRAF—liver cancer	0.000663	0.00289	CbGpPWpGaD
Tolcapone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000653	0.000886	CcSEcCtD
Tolcapone—Paraesthesia—Doxorubicin—liver cancer	0.000644	0.000873	CcSEcCtD
Tolcapone—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.00064	0.0028	CbGpPWpGaD
Tolcapone—Dyspnoea—Doxorubicin—liver cancer	0.000639	0.000867	CcSEcCtD
Tolcapone—Feeling abnormal—Epirubicin—liver cancer	0.000639	0.000866	CcSEcCtD
Tolcapone—Somnolence—Doxorubicin—liver cancer	0.000637	0.000865	CcSEcCtD
Tolcapone—Gastrointestinal pain—Epirubicin—liver cancer	0.000634	0.00086	CcSEcCtD
Tolcapone—Dyspepsia—Doxorubicin—liver cancer	0.000631	0.000856	CcSEcCtD
Tolcapone—Decreased appetite—Doxorubicin—liver cancer	0.000623	0.000846	CcSEcCtD
Tolcapone—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000619	0.00084	CcSEcCtD
Tolcapone—Fatigue—Doxorubicin—liver cancer	0.000618	0.000839	CcSEcCtD
Tolcapone—Urticaria—Epirubicin—liver cancer	0.000616	0.000835	CcSEcCtD
Tolcapone—Constipation—Doxorubicin—liver cancer	0.000613	0.000832	CcSEcCtD
Tolcapone—Pain—Doxorubicin—liver cancer	0.000613	0.000832	CcSEcCtD
Tolcapone—Abdominal pain—Epirubicin—liver cancer	0.000613	0.000831	CcSEcCtD
Tolcapone—Body temperature increased—Epirubicin—liver cancer	0.000613	0.000831	CcSEcCtD
Tolcapone—CYP2C9—Metapathway biotransformation—GPX3—liver cancer	0.000609	0.00266	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CPT1B—liver cancer	0.0006	0.00262	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GLUL—liver cancer	0.0006	0.00262	CbGpPWpGaD
Tolcapone—Feeling abnormal—Doxorubicin—liver cancer	0.000591	0.000802	CcSEcCtD
Tolcapone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000586	0.000795	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—HPGDS—liver cancer	0.000581	0.00254	CbGpPWpGaD
Tolcapone—COMT—Metabolism—NR1H4—liver cancer	0.000579	0.00253	CbGpPWpGaD
Tolcapone—Hypersensitivity—Epirubicin—liver cancer	0.000571	0.000775	CcSEcCtD
Tolcapone—Urticaria—Doxorubicin—liver cancer	0.00057	0.000773	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTA3—liver cancer	0.000569	0.00249	CbGpPWpGaD
Tolcapone—Body temperature increased—Doxorubicin—liver cancer	0.000567	0.000769	CcSEcCtD
Tolcapone—Abdominal pain—Doxorubicin—liver cancer	0.000567	0.000769	CcSEcCtD
Tolcapone—Asthenia—Epirubicin—liver cancer	0.000556	0.000754	CcSEcCtD
Tolcapone—COMT—Neuronal System—RAF1—liver cancer	0.000553	0.00242	CbGpPWpGaD
Tolcapone—Pruritus—Epirubicin—liver cancer	0.000548	0.000744	CcSEcCtD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000537	0.00235	CbGpPWpGaD
Tolcapone—Diarrhoea—Epirubicin—liver cancer	0.00053	0.000719	CcSEcCtD
Tolcapone—Hypersensitivity—Doxorubicin—liver cancer	0.000528	0.000717	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTA4—liver cancer	0.000521	0.00227	CbGpPWpGaD
Tolcapone—Asthenia—Doxorubicin—liver cancer	0.000514	0.000698	CcSEcCtD
Tolcapone—Dizziness—Epirubicin—liver cancer	0.000512	0.000695	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTA2—liver cancer	0.000507	0.00222	CbGpPWpGaD
Tolcapone—Pruritus—Doxorubicin—liver cancer	0.000507	0.000688	CcSEcCtD
Tolcapone—Vomiting—Epirubicin—liver cancer	0.000493	0.000668	CcSEcCtD
Tolcapone—Diarrhoea—Doxorubicin—liver cancer	0.000491	0.000666	CcSEcCtD
Tolcapone—COMT—Metabolism—GSTA1—liver cancer	0.000489	0.00214	CbGpPWpGaD
Tolcapone—Rash—Epirubicin—liver cancer	0.000489	0.000663	CcSEcCtD
Tolcapone—Dermatitis—Epirubicin—liver cancer	0.000488	0.000662	CcSEcCtD
Tolcapone—Headache—Epirubicin—liver cancer	0.000485	0.000659	CcSEcCtD
Tolcapone—COMT—Metabolism—NAT2—liver cancer	0.000484	0.00211	CbGpPWpGaD
Tolcapone—Dizziness—Doxorubicin—liver cancer	0.000474	0.000643	CcSEcCtD
Tolcapone—CYP2C9—Biological oxidations—CYP2E1—liver cancer	0.000474	0.00207	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP2E1—liver cancer	0.000467	0.00204	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALDOB—liver cancer	0.000464	0.00203	CbGpPWpGaD
Tolcapone—Nausea—Epirubicin—liver cancer	0.00046	0.000624	CcSEcCtD
Tolcapone—Vomiting—Doxorubicin—liver cancer	0.000456	0.000618	CcSEcCtD
Tolcapone—Rash—Doxorubicin—liver cancer	0.000452	0.000613	CcSEcCtD
Tolcapone—Dermatitis—Doxorubicin—liver cancer	0.000452	0.000613	CcSEcCtD
Tolcapone—Headache—Doxorubicin—liver cancer	0.000449	0.000609	CcSEcCtD
Tolcapone—COMT—Metabolism—CRABP1—liver cancer	0.000443	0.00193	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GGT1—liver cancer	0.000435	0.0019	CbGpPWpGaD
Tolcapone—Nausea—Doxorubicin—liver cancer	0.000426	0.000578	CcSEcCtD
Tolcapone—COMT—Transmission across Chemical Synapses—HRAS—liver cancer	0.000398	0.00174	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTP1—liver cancer	0.000391	0.00171	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HPGDS—liver cancer	0.000387	0.00169	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTP1—liver cancer	0.000385	0.00168	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—GSTM1—liver cancer	0.000359	0.00157	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—GSTM1—liver cancer	0.000354	0.00155	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000346	0.00151	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PSMA4—liver cancer	0.000345	0.00151	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PSMD10—liver cancer	0.000345	0.00151	CbGpPWpGaD
Tolcapone—CYP2C9—Biological oxidations—CYP1A1—liver cancer	0.00034	0.00149	CbGpPWpGaD
Tolcapone—CYP2C9—Metapathway biotransformation—CYP1A1—liver cancer	0.000336	0.00147	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GOT2—liver cancer	0.000335	0.00146	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000334	0.00146	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP2E1—liver cancer	0.000315	0.00138	CbGpPWpGaD
Tolcapone—COMT—Neuronal System—HRAS—liver cancer	0.000305	0.00133	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYCS—liver cancer	0.000295	0.00129	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GGT1—liver cancer	0.00029	0.00126	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GOT1—liver cancer	0.00029	0.00126	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTP1—liver cancer	0.00026	0.00114	CbGpPWpGaD
Tolcapone—COMT—Metabolism—HMOX1—liver cancer	0.000257	0.00112	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000255	0.00111	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—UGDH—liver cancer	0.000254	0.00111	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—EPT1—liver cancer	0.000239	0.00104	CbGpPWpGaD
Tolcapone—COMT—Metabolism—GSTM1—liver cancer	0.000239	0.00104	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—TAT—liver cancer	0.000227	0.00099	CbGpPWpGaD
Tolcapone—COMT—Metabolism—CYP1A1—liver cancer	0.000227	0.00099	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000223	0.000974	CbGpPWpGaD
Tolcapone—COMT—Metabolism—MTHFR—liver cancer	0.000211	0.000922	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARA—liver cancer	0.000207	0.000905	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CG—liver cancer	0.000178	0.000775	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PPARG—liver cancer	0.000171	0.000748	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000167	0.000729	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CD—liver cancer	0.000156	0.000681	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GLUL—liver cancer	0.000154	0.000673	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CPT1B—liver cancer	0.000154	0.000673	CbGpPWpGaD
Tolcapone—COMT—Metabolism—ALB—liver cancer	0.000154	0.000673	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NR1H4—liver cancer	0.000149	0.000649	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA3—liver cancer	0.000146	0.000638	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CB—liver cancer	0.000136	0.000594	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA4—liver cancer	0.000134	0.000584	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000131	0.00057	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA2—liver cancer	0.00013	0.000569	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTA1—liver cancer	0.000126	0.000549	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—NAT2—liver cancer	0.000124	0.000543	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000119	0.000522	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALDOB—liver cancer	0.000119	0.00052	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CRABP1—liver cancer	0.000114	0.000496	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000102	0.000447	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HPGDS—liver cancer	9.93e-05	0.000434	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—liver cancer	9.88e-05	0.000431	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	9e-05	0.000393	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—liver cancer	8.88e-05	0.000388	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PSMD10—liver cancer	8.85e-05	0.000387	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PSMA4—liver cancer	8.85e-05	0.000387	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GOT2—liver cancer	8.61e-05	0.000376	CbGpPWpGaD
Tolcapone—COMT—Metabolism—PIK3CA—liver cancer	8.29e-05	0.000362	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP2E1—liver cancer	8.1e-05	0.000354	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	7.84e-05	0.000342	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYCS—liver cancer	7.58e-05	0.000331	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GOT1—liver cancer	7.43e-05	0.000325	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GGT1—liver cancer	7.43e-05	0.000325	CbGpPWpGaD
Tolcapone—COMT—Metabolism—AKT1—liver cancer	6.77e-05	0.000296	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTP1—liver cancer	6.68e-05	0.000292	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—HMOX1—liver cancer	6.59e-05	0.000288	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—GSTM1—liver cancer	6.14e-05	0.000268	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—CYP1A1—liver cancer	5.82e-05	0.000254	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—MTHFR—liver cancer	5.42e-05	0.000237	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARA—liver cancer	5.32e-05	0.000232	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	4.78e-05	0.000209	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CG—liver cancer	4.56e-05	0.000199	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PPARG—liver cancer	4.4e-05	0.000192	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CD—liver cancer	4.01e-05	0.000175	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—ALB—liver cancer	3.95e-05	0.000173	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CB—liver cancer	3.49e-05	0.000152	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—PIK3CA—liver cancer	2.13e-05	9.29e-05	CbGpPWpGaD
Tolcapone—CYP2C9—Metabolism—AKT1—liver cancer	1.74e-05	7.59e-05	CbGpPWpGaD
